Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20448123.
- Also identified by DOI 10.1136/hrt.2009.186189.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Periprocedural myocardial injury (PMI) is common after percutaneous coronary intervention (PCI). Periprocedural infarction (myocardial infarction type 4a) occurs after at least 10% of PCI procedures and has an impact on long-term prognosis. Measurement of biomarkers to allow assessment of PMI is an important tool for clinical and research purposes and should be routine after every PCI (troponin I or T and CK-MB). The importance of oral and intravenous antiplatelet agents and other drugs which have been proven to reduce PMI is discussed.
Medical subject headings
- Angioplasty, Balloon, Coronary
- Heart Injuries